Category: by journal

Lead author changes co-author’s name on a paper without his permission. Why?

Here’s a rather odd case: A postdoctoral researcher says his former boss changed his name on a paper without his permission. According to the postdoc, Antonio Herrera-Merchan, his principal investigator at University of Granada insisted on the name change to distance them both from a scandal in Herrera-Merchan’s previous lab.

After publishing a paper in Oncotarget in October 2017, Herrera-Merchan’s name was changed on the paper. Now, two versions of the paper exist: an earlier version that lists Antonio Herrera-Merchan as first author, and the current version that spells his name without “Merchan.”*  

We’ve obtained an email exchange between his former boss, Pedro Medina, and Oncotarget, requesting the name change.

Medina told us Herrera-Merchan always used the name “Herrera” in his lab: Continue reading Lead author changes co-author’s name on a paper without his permission. Why?

Caught Our Notice: Unusual — journal flags paper for concerns, then updates them

Via Wikimedia

Title: Filled and peptide-modified single-walled carbon nanotubes: synthesis, characterization, and in vitro test for cancer cell targeting

What Caught Our Attention: After an expression of concern (EOC) is published in a journal, the usual procedure is to either publish a subsequent correction or retraction — or, unfortunately, leave it sit ad infinitum. But apparently, there’s another option. Continue reading Caught Our Notice: Unusual — journal flags paper for concerns, then updates them

Caught Our Notice: After ORI flags a paper by former grad student, university flags another

Via Wikimedia

Title: The L3MBTL3 Methyl-Lysine Reader Domain Functions As a Dimer

What Caught Our Attention: Six months ago, the U.S. Office of Research Integrity (ORI) determined that former graduate student Brandi Baughman had doctored 11 figures in a PLOS ONE article, which was retracted shortly after.  The PLOS ONE paper listed two affiliations for Baughman — the National Institute of Environmental Health Sciences and the University of North Carolina, Chapel Hill (UNC); now UNC has triggered a second retraction of a paper co-authored by Baughman, also due to research misconduct. Although the ORI notice makes no mention of this additional paper, the agency recently took a “targeted approach” by not issuing comprehensive findings of misconduct for one researcher, in order to conserve resources. Of course, sometimes universities make findings that don’t meet the ORI’s bar, too. Continue reading Caught Our Notice: After ORI flags a paper by former grad student, university flags another

Another retraction to appear for Cornell food scientist Brian Wansink

Brian Wansink

The new year will bring a sixth retraction for food scientist Brian Wansink, whose work has been under fire for all of 2017.

Although the notice has not yet been released, the journal Appetite plans to retract a 2003 paper about the different forces that motivate people to try new foods (referring, in this specific context, to soy).

It’s unclear why “Profiling taste-motivated segments” is being retracted (we asked the journal, but haven’t immediately heard back); some potential issues were flagged in March by Nick Brown, a PhD student who has devoted hundreds of hours to analyzing Wansink’s work (and forwarded us the email from Appetite confirming the upcoming retraction).

For instance, Brown alleged the article contains duplicated material, and similarities to the results from another 2002 paper that also measured soy consumption. After analyzing those two papers and a 2004 paper (also about eating soy), Brown concluded:

Continue reading Another retraction to appear for Cornell food scientist Brian Wansink

Caught Our Notice: Researcher who sued PubPeer commenter draws 19th retraction  

Via Wikimedia

Title: Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells

What Caught Our Attention: We’ve been following cancer scientist Fazlul Sarkar for years, as he (unsuccessfully) sought to expose the identity of a PubPeer commenter who he believes cost him a job offer. In November 2016, the ACLU released a copy of a misconduct investigation report compiled by Wayne State University, which concluded Sarkar ran a laboratory “culture” of “fabrication, falsification and/or plagiarism of data,” and recommended the retraction of 42 papers and correction of 10 papers. He’s now lodged his 19th retraction. Continue reading Caught Our Notice: Researcher who sued PubPeer commenter draws 19th retraction  

JAMA journal calls for formal investigation into surgery group’s work

A JAMA journal has issued an expression of concern for a 2013 paper after discovering “substantial overlap” with a recently retracted paper in another journal.

In April 2017, the editors of JAMA Otolaryngology − Head & Neck Surgery received allegations that the paper included data that had been published in other journals. After investigating, the editors discovered extensive overlap between several sections of the JAMA paper and a now-retracted 2015 paper by the same group. The 2015 paper, published in the Journal of the American College of Surgeons (JACS), was pulled in July 2017, after the editors determined the statistical results were “incorrect” and “the data do not support the conclusions of the article.”

Given the overlap between the two papers, the JAMA editors contacted the University of L’Aquila, where the authors work, to request a formal investigation to evaluate the “integrity of the research.” Jay Piccirillo, the editor of JAMA Otolaryngology − Head & Neck Surgery, told us:

Continue reading JAMA journal calls for formal investigation into surgery group’s work

Paper retracted when co-author forgets he had published a figure before

A 2016 case study in Neurology exploring a “mystery case” has been retracted because four figures had already been published in a 2012 article.

The two papers have three authors in common, but according to the retraction notice, none could explain the duplicate publication. The notice states that Pierre Labauge, the corresponding author on the 2012 paper and the last author on the Neurology paper, said he “did not remember the first paper” when revising the recent one. Continue reading Paper retracted when co-author forgets he had published a figure before

One image was duplicated in eight papers. Yes, eight.

A cancer journal has retracted a 2014 paper after discovering one image had been duplicated in seven other papers. That’s right—the same image appeared in a total of eight papers.

For some of the papers, the issues went beyond the single image. According to the retraction notice, several papers contained other duplicated images, as well as “overlapping text.”  The notice, published in October 2017 in Asian Pacific Journal of Cancer Prevention (APJCP), is essentially a letter PLOS ONE wrote to several journals, informing them of the issues in the eight papers, all published between 2014 and 2016. The letter mentions that one of the papers—a 2016 analysis in Korean Journal of Physiology (KJPP)—had already been retracted earlier this year. One author of the retracted KJPP paper confessed to using a company to prepare and submit the manuscript. Continue reading One image was duplicated in eight papers. Yes, eight.

Caught Our Notice: Using this research tool? You’d better ask first

Via Wikimedia

Title: Patient Education After CABG: Are We Teaching the Wrong Information?

What Caught Our Attention: We’ve written about the controversy surrounding a commonly used tool to measure whether patients are sticking to their drug regimen, known as the Morisky Medication Adherence Scale (MMAS-8). It can cost thousands of dollars — and using it without payment/permission earns researchers a call from a collector, who has used legal threats to compel multiple teams to withdraw their papers (a phenomenon we wrote about in Science). The creator of the tool argues it’s copyrighted, and demanding fees ensures researchers use it properly, which avoids putting patients at risk. We’ve found a notice (paywalled, tsk-tsk) that reveals another group of authors used the tool without permission and, according to the notice, “incorrectly.”

Continue reading Caught Our Notice: Using this research tool? You’d better ask first

University finds falsified data in PNAS gene therapy paper, authors retract

A university investigation has found falsified data in a 2011 paper about the side effects of a virus commonly used in gene therapy.

The authors are retracting the paper, but one co-author told Retraction Watch they stand by their main conclusions. According to Roland Herzog, a professor at the University of Florida (UF) College of Medicine and a co-author of the paper, the falsified data were related to a minor part of the paper.

The paper, “Activation of the NF-κB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy,” was published in the Proceedings of the National Academy of Sciences (PNAS) in March 2011. All authors were affiliated with UF at the time; the handling editor, Kenneth Berns, is an emeritus professor at UF. The paper has been cited 50 times, according to Clarivate Analytics’ Web of Science. Continue reading University finds falsified data in PNAS gene therapy paper, authors retract